Why a registry of Chronic Urticaria (CUR) is needed

R M Gómez1,2, E Jares3, G W Canonica4

  • 1Fundación Ayre at Instituto Médico Alas, Sarmiento 771, 330-31, 4400 Salta, Argentina.

Insights

Establishing a chronic urticaria (CU) registry offers significant benefits for understanding disease pathogenesis and improving patient care. This informatics strategy can enhance epidemiological studies and guide localized treatment approaches.

Area of Science:

  • Allergy and Immunology
  • Dermatology
  • Health Informatics

Background:

  • Chronic urticaria (CU) significantly impacts patient quality of life, with ongoing needs in understanding its pathogenesis and treatment.
  • Registries for chronic non-communicable diseases, like diabetes mellitus, have yielded substantial knowledge and improved management strategies.
  • Allergic disease registries are gaining recognition, highlighting the potential for structured data collection.

Purpose of the Study:

  • To introduce the first chronic urticaria (CU) registry, detailing its parameters for patient identification, evaluation, and management.
  • To underscore the potential of informatics strategies in enhancing the care of chronic illnesses like CU.
  • To establish the registry as a valuable tool for epidemiological and clinical research planning.

Main Methods:

  • Development of the first chronic urticaria (CU) registry, accessible online.
  • Inclusion of parameters for patient identification, disease evaluation, and management within the registry.
  • Utilization of validated instruments for data collection and comparison across different sites.

Main Results:

  • The CU registry provides a framework for collecting essential patient data.
  • It serves as a platform for epidemiological studies and clinical research planning, including feasibility and enrollment assessments.
  • The registry can generate data to adapt guidelines and diagnostic approaches for local populations.

Conclusions:

  • Informatics strategies, exemplified by the CU registry, can significantly improve the care of chronic illnesses.
  • The registry is a valid instrument for epidemiological research and clinical trial planning.
  • Data from the registry can inform the development of cost-effective interventions and localized treatment guidelines.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
32.7K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
80
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
87
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
69